CIC
GILD icon

Chase Investment Counsel’s Gilead Sciences GILD Stock Holding History

Chase Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$646K Hold
5,121
– – 0.14% 93
2026
Q1 		$713K Hold
5,121
– – 0.19% 94
2025
Q4 		$628K Sell
5,121
-20
-0.4% -$2.43K 0.18% 88
2025
Q3 		$570K Sell
5,141
-5,153
-50% -$586K 0.17% 93
2025
Q2 		$1.14M Buy
10,294
+2,349
+30% +$250K 0.36% 63
2025
Q1 		$890K Hold
7,945
– – 0.33% 72
2024
Q4 		$733K Buy
+7,945
New +$715K 0.24% 79
2022
Q1 		– Sell
-3,177
Closed -$230K – 126
2021
Q4 		$230K Buy
3,177
+28
+0.9% +$1.93K 0.09% 102
2021
Q3 		$219K Buy
3,149
+89
+3% +$6.25K 0.09% 96
2021
Q2 		$210K Buy
+3,060
New +$204K 0.09% 99
2016
Q2 		– Sell
-48,659
Closed -$4.47M – 102
2016
Q1 		$4.47M Buy
48,659
+385
+0.8% +$34.7K 1.95% 25
2015
Q4 		$4.88M Sell
48,274
-1,801
-4% -$187K 1.95% 22
2015
Q3 		$4.92M Sell
50,075
-1,735
-3% -$193K 1.99% 21
2015
Q2 		$6.07M Sell
51,810
-1,280
-2% -$140K 2.21% 13
2015
Q1 		$5.21M Sell
53,090
-9,138
-15% -$928K 1.83% 27
2014
Q4 		$5.87M Sell
62,228
-4,568
-7% -$472K 2.09% 14
2014
Q3 		$7.11M Sell
66,796
-13,708
-17% -$1.34M 2.55% 2
2014
Q2 		$6.67M Sell
80,504
-3,987
-5% -$310K 2.26% 6
2014
Q1 		$5.99M Sell
84,491
-17,919
-17% -$1.41M 2.03% 12
2013
Q4 		$7.69M Sell
102,410
-40,890
-29% -$2.85M 2.28% 5
2013
Q3 		$9.01M Sell
143,300
-1,300
-0.9% -$77.7K 2.31% 10
2013
Q2 		$7.41M Buy
+144,600
New +$7.54M 1.98% 23

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Chase Investment Counsel's GILD Position: Q2 2026 in Review

Chase Investment Counsel held its Gilead Sciences (GILD) position steady in Q2 2026 at 5,121 shares worth $646K. The position accounts for 0.14% of the portfolio, ranked #93.

Chase Investment Counsel first reported a position in GILD in Q2 2013 and has held it in 22 quarters since. The position peaked at $9.01M in Q3 2013. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Chase Investment Counsel held 5,121 shares of Gilead Sciences worth $646K as of Q2 2026.
  • Chase Investment Counsel left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.14% of Chase Investment Counsel's portfolio in Q2 2026, its #93 holding.
  • Chase Investment Counsel first reported a position in Gilead Sciences in Q2 2013 and has held it in 22 quarters since.
  • Chase Investment Counsel's Gilead Sciences position peaked at $9.01M in Q3 2013.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Chase Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.